FDA Investigator Jessica S Estriplet

Jessica S Estriplet has conducted inspections on 23 sites in 3 countries as of 06 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
23
Last Inspection Date:
06 May 2024
Investigator Role:
FDA Investigator
Redica ID:
100007224
Countries of Inspections:
United States of America, China, Canada
FDA Investigators that have inspected at least one site in common with Jessica S Estriplet:
Addam S Reynolds, Adetutu M Gidado, Alberto A Viciedo, Alice S Tsao, Alisha B Patel, Allen Lou, Amy L Singer, Anita R Michael, Ankur C Patel, Annemarie B Randow, Annemarie Bodnar, Annet R Rajan, Anthony J Donato, Atul J Agrawal, Barbara J Maulfair, Brandy N Lepage, Brian S Keefer, Cara M Minelli, Carl A Perez, Cassandra L Abellard, Charlotte E Wilkins, Christina K Theodorou, Concepcion Cruz, Jr, Craig D Zagata, Daniel J Grabicki, Daniel T Lee, David J Hafner, Denise M Digiulio, Dongping Dai, PhD, Douglas C Kovacs, Edward D Mcdonald, Eileen A Liu, Emmanuel Jramos Maldonado, Emmanuel T Donyina, Eric J Cunningham, Eric Rothschild, Esther C Broner, PhD, Frank J Marciniak, Frederick F Razzaghi, Guerlain Ulysse, Helen B Ricalde, Helen Verdel, James M Mason, James Norman, James R Birkenstamm, Janet A Rajan, Jay B Shah, Jazmine N Brown, Jenny Sung, Jogy George, John P Mistler, Jonathan S Helfgott, Jose M Cayuela, Josh Renzo N Ramilo, Joy Rkozlowski Klena, Juanita P Versace, Junho Pak, Justine Tomasso, Karen A Briggs, Karen E D'orazio, Kelli F Dobilas, Kinh Q Mac, Kristina J Donohue, Kristy A Zielny, Lata C Mathew, PhD, Lauren L Vajo, LCDR Susan E Polifko, Li Li, Liatte Kreuger, PharmD, Lisa M Bellows, Loretta Nemchik, Marcellinus D Dordunoo, Marcia D Fields, Mary R Kirker, Melba Trivera Clavell, Melissa A Zuppe, Melissa T Roy, Meyer J Slobotsky, Michael A Taylor, Michael R Goga, Michael R Klapal, Nancy F Scheraga, Nancy M Espinal, Nerizza B Guerin, Nicholas A Violand, Niketa Patel, Nikki S Ramirez, Paige R Mccoy, Patrick C Klotzbuecher, Paul L Bellamy, Peter R Lenahan, Rachel C Harrington, Regina T Brown, Robert G Ruff, Rose Ljean Mary, Russell J Glapion, Saleem A Akhtar, Samir C Gala, Satheesh K Podaralla, Sena G Dissmeyer, Sherry G Bous, Simone E Pitts, Stephen J Mottola, Stephenie M Ortiz, Suchan Kim, Susan F Laska, MS, Tara G Bizjak, Tarun D Mehta, Thomas E Friel, Thomas J Arista, Tiffani D Wilson, Tonia F Bernard, Travis R Hunt, Unnee Ranjan, Valerie C Reed, Victoria Spivak, Vlada Matusovsky, Wei Wang, PhD, William J Leonard, William J Muszynski, Xiuju Lu, Yoriann M Cabrera Bartolomei, Yvesna C Blaise, Yvins Dezan, Zakaria I Ganiyu, Zhong Li, PhD

Jessica S Estriplet's Documents

Publish Date Document Type Title
August, 2023 FDA 483 Inopak Ltd - Form 483, 2023-08-03
January, 2022 EIR Sharp Packaging Services, LLC - EIR, 2022-01-28
November, 2021 FDA 483 STIRA PHARMACEUTICALS LLC - Form 483, 2021-11-05
August, 2022 FDA 483 AARKISH PHARMACEUTICALS NJ INC. - Form 483, 2022-08-18
January, 2023 FDA 483 Jamol Laboratories, Inc. - Form 483, 2023-01-12
March, 2024 FDA 483 Dermaceutical Laboratories Limited Liability Company - Form 483, 2024-03-01
April, 2021 EIR Gateway Analytical - EIR, 2021-04-14
March, 2022 FDA 483 Elvi Pharma LLC. - Form 483, 2022-03-25
July, 2021 FDA 483 Response Colonia Care Pharmacy - Form 483R, 2021-08-17
January, 2022 FDA 483 Sharp Packaging Services, LLC - Form 483, 2022-01-28
July, 2022 FDA 483 Innovation Labs, Inc. - Form 483, 2022-07-05
November, 2022 FDA 483 Teva Pharmaceuticals USA, Inc. - Form 483, 2022-11-10
June, 2023 FDA 483 AIRGAS USA, LLC - Form 483, 2023-06-21
July, 2021 FDA 483 Colonia Care Pharmacy - Form 483, 2021-07-26
November, 2021 EIR STIRA PHARMACEUTICALS LLC - EIR, 2021-11-22
June, 2022 FDA 483 ARx, LLC - Form 483, 2022-06-03
January, 2022 FDA 483 Response Sharp Packaging Services, LLC - Form 483R, 2022-02-17
September, 2023 FDA 483 International Trading Pharm Lab Inc - Form 483, 2023-09-21
September, 2022 FDA 483 Curexa - East, LLC dba Curexa - Form 483, 2022-09-09
March, 2023 EIR GRANULATION TECHNOLOGY, INC. - EIR, 2023-04-14

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more